TY - JOUR AU - Miri, S. M. PY - 2020 DA - 2020// TI - CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy JO - Caner Cell Int VL - 20 UR - https://doi.org/10.1186/s12935-020-01546-8 DO - 10.1186/s12935-020-01546-8 ID - Miri2020 ER -